Heart Failure in Type 2 Diabetes: Improving the Risk Model - Endocrinology Advisor


Heart Failure in Type 2 Diabetes: Improving the Risk Model
Endocrinology Advisor
Researchers conducted a nested case-cohort study in a group of participants from the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation; ClinicalTrials.gov identifier: NCT00145925) clinical ...



from diabetes - Google News